{"DataElement":{"publicId":"7643131","version":"1","preferredName":"Ancillary Study KIT Gene Mutation Type","preferredDefinition":"A response to indicate the type of molecular genetic abnormality associated with the mutation of the c-kit (CD117) proto-oncogene in the development of gastrointestinal stromal tumor as part of secondary study data.","longName":"7643096v1.0:7643117v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7643096","version":"1","preferredName":"Ancillary Study KIT Gene Mutation","preferredDefinition":"A study that is secondary to another study._A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","longName":"7052721v1.0:7643094v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7052721","version":"1","preferredName":"Ancillary Study","preferredDefinition":"A study that is secondary to another study.","longName":"C16041","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ancillary Study","conceptCode":"C16041","definition":"A study that is secondary to another study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"973C983C-51FC-1152-E053-F662850AE6FF","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7643094","version":"1","preferredName":"KIT Gene Mutation","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","longName":"C39712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6779D-D767-4655-E053-4EBD850A3E57","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6779D-D778-4655-E053-4EBD850A3E57","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7643117","version":"1","preferredName":"KIT Gene Mutation Type","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas._Something distinguishable as an identifiable class based on common qualities.","longName":"7643117v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other KIT mutation","valueDescription":"Is Another KIT Mutation Present","ValueMeaning":{"publicId":"7643119","version":"1","preferredName":"Is Another KIT Mutation Present","longName":"7643119","preferredDefinition":"A question to determine if a KIT mutation that is not listed on the form was found in the study.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Is Another KIT Mutation Present","conceptCode":"C158937","definition":"A question to determine if a KIT mutation that is not listed on the form was found in the study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-316A-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0F6783B-3183-54C1-E053-4EBD850AB455","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","deletedIndicator":"No"},{"value":"KIT W557R (c.1669T>A) mutation","valueDescription":"KIT NM_000222.2:c.1669T>A","ValueMeaning":{"publicId":"7643121","version":"1","preferredName":"KIT NM_000222.2:c.1669T>A","longName":"7643121","preferredDefinition":"A nucleotide substitution at position 1669 of the coding sequence of the KIT gene where thymine has been mutated to adenine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT NM_000222.2:c.1669T>A","conceptCode":"C158897","definition":"A nucleotide substitution at position 1669 of the coding sequence of the KIT gene where thymine has been mutated to adenine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-3190-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0F6783B-31A9-54C1-E053-4EBD850AB455","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","deletedIndicator":"No"},{"value":"KIT V559A (c.1676T>C) mutation","valueDescription":"KIT NM_000222.2:c.1676T>C","ValueMeaning":{"publicId":"7643123","version":"1","preferredName":"KIT NM_000222.2:c.1676T>C","longName":"7643123","preferredDefinition":"A nucleotide substitution at position 1676 of the coding sequence of the KIT gene where thymine has been mutated to cytosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT NM_000222.2:c.1676T>C","conceptCode":"C158896","definition":"A nucleotide substitution at position 1676 of the coding sequence of the KIT gene where thymine has been mutated to cytosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-31B6-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0F6783B-31CF-54C1-E053-4EBD850AB455","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","deletedIndicator":"No"},{"value":"KIT K642E (c.1942A>G) mutation","valueDescription":"KIT NM_000222.2:c.1924A>G","ValueMeaning":{"publicId":"7643125","version":"1","preferredName":"KIT NM_000222.2:c.1924A>G","longName":"7643125","preferredDefinition":"A nucleotide substitution at position 1924 of the coding sequence of the KIT gene where adenine has been mutated to guanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT NM_000222.2:c.1924A>G","conceptCode":"C155680","definition":"A nucleotide substitution at position 1924 of the coding sequence of the KIT gene where adenine has been mutated to guanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-31DC-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0F6783B-31F5-54C1-E053-4EBD850AB455","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","deletedIndicator":"No"},{"value":"KIT L576P (c.1727T>C) mutation","valueDescription":"KIT NM_000222.2:c.1727T>C","ValueMeaning":{"publicId":"7643127","version":"1","preferredName":"KIT NM_000222.2:c.1727T>C","longName":"7643127","preferredDefinition":"A nucleotide substitution at position 1727 of the coding sequence of the KIT gene where thymine has been mutated to cytosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT NM_000222.2:c.1727T>C","conceptCode":"C158895","definition":"A nucleotide substitution at position 1727 of the coding sequence of the KIT gene where thymine has been mutated to cytosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-3202-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0F6783B-321B-54C1-E053-4EBD850AB455","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","deletedIndicator":"No"},{"value":"No mutation detected","valueDescription":"KIT Gene Mutation Negative","ValueMeaning":{"publicId":"5962041","version":"1","preferredName":"KIT Gene Mutation Negative","longName":"5962041","preferredDefinition":"A genetic finding indicating that KIT gene mutations have not been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation Negative","conceptCode":"C138194","definition":"A genetic finding indicating that KIT gene mutations have not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5889E5B2-278F-467E-E053-F662850A78FA","latestVersionIndicator":"Yes","beginDate":"2017-09-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-09-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0F6783B-322F-54C1-E053-4EBD850AB455","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7643116","version":"1","preferredName":"KIT Gene Mutation Type","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.:Something distinguishable as an identifiable class based on common qualities.","longName":"C39712:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-3140-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-3151-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":"7/28/21 jk added max length, chg ALPHANUMERIC to Character for new MDR.  4/27/21 ls created for Phase 3 CM Baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"KIT Mutation","type":"Preferred Question Text","description":"KIT Mutation","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6CC03-3925-2708-E053-4EBD850A491B","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":"7/27/21 jk created for Phase 3 CM Baseline CRF.","administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}